The team behind the technology

Project Screen by Prenetics is an initiative developed by Prenetics, a healthcare company with headquarters in London and Hong Kong.

Read More

Prenetics leadership team

Avi Lasarow

Chief Executive Officer of Prenetics EMEA

Andrew Steele

Chief Product Officer, Prenetics EMEA

Sath Nirmalananthan

Chief Financial Officer, EMEA

Arjun Agarwal

Chief Strategy Officer, EMEA

Jackie Dowd

Chief People Officer, EMEA

Brian Stephenson

SVP Market Development

Dr Matt Sims

Laboratory Director, EMEA

Peter Wong

Chief Technology Officer

Prenetics’ expert scientific consortium

Dr. Rachel Liebmann

Group Medical Director, The Doctor’s Laboratory and Vice President of the Royal College of Pathologists

Dr. Mark Atkin

Consultant Virologist, The Doctor’s Laboratory

Dr. Senthil Sundaram, MD

Chief Clinical Officer at Prenetics; Leads clinical development of molecular genetic testing

Dr. Lawrence Tzang CH, BSc, PhD, Reg MLT

Chief Scientific Officer & Laboratory Director of Prenetics COVID-19 Screening Facility

Scientific working group

Prof. Alan McNally, BSC, PhD

Director of Institute of Microbiology and Infection, University of Birmingham

Prof. Willem Van Schaik, MSc, PhD

Institute of Microbiology and infection, University of Birmingham

Prof. Michael M Yang, PhD

Head and Chair Professor, Department of Biomedical Sciences at City University of Hong Kong

Dr. Richard H. Kaszynski, M.A, M.D,PhD

Co-Founder: Stanford Solutions, a healthcare innovation group founded out of Standard University School of Medicine. Executive Director, Shinwakai Medical Group, Tokyo, Japan

Company Address: Prenetics EMEA Ltd, Unit 2, Orpington Business Park, Faraday Way, Orpington, Kent BR5 3AA, United Kingdom

Company Registration Number: 08834823

© 2022 Project Screen | Privacy Policy | Terms of Service | Cookies Policy | All rights reserved